Junyan Shu
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Immunology top 10%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- interferon and immune responses
Papers in
-
- Cell death mechanisms and regulation 2
- Oncology 5
- Cancer-related Molecular Pathways 2
- Lung Cancer Research Studies 1
- Co-authors
- Genhong Cheng (2 shared papers)Hajir Dadgostar (1 shared paper)Qingwen Cheng (1 shared paper)Ho H. Lee (1 shared paper)Dennis W. Stacey (5 shared papers)Xiaolan Zhou (1 shared paper)John R. Stevenson (1 shared paper)Guan Chen (1 shared paper)
- Journals
- Oncogene (2 papers)Neurosurgery (1 paper)Journal of Biological Chemistry (1 paper)Cellular Immunology (1 paper)Journal of Biotechnology (1 paper)
- Partner nations
- United StatesIndiaBulgaria
In The Last Decade
Junyan Shu
10 papers receiving 725 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 267
- Immunology 303
- Oncology 165
- Molecular Biology 396
- Behavioral Neuroscience 18
Countries citing papers authored by Junyan Shu
This map shows the geographic impact of Junyan Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Shu more than expected).
Fields of papers citing papers by Junyan Shu
This network shows the impact of papers produced by Junyan Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Shu. The network helps show where Junyan Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyan Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 466 | |
| 2 | 1993 | 58 | |
| 3 | 1997 | 55 | |
| 4 | 1999 | 37 | |
| 5 | 1999 | 28 | |
| 6 | 1996 | 27 | |
| 7 | 1998 | 26 | |
| 8 | Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells. | 1996 | 24 |
| 9 | 2020 | 12 | |
| 10 | 1994 | 1 |
About Junyan Shu
Junyan Shu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Surgery, having authored 10 papers that have together received 734 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (2 papers), Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers), Immune Response and Inflammation (2 papers), Cancer Mechanisms and Therapy (1 paper), Lung Cancer Research Studies (1 paper), Biochemical effects in animals (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Cancer Research (267 citations), Immunology (303 citations), Oncology (165 citations), Molecular Biology (396 citations) and Behavioral Neuroscience (18 citations). Junyan Shu has collaborated with scholars based in United States, India and Bulgaria. Frequent co-authors include Genhong Cheng, Hajir Dadgostar, Qingwen Cheng, Ho H. Lee, Dennis W. Stacey, Xiaolan Zhou, John R. Stevenson, Guan Chen, Masahiro Hitomi and Zhengbin Yao. Their work appears in journals such as Oncogene, Neurosurgery, Journal of Biological Chemistry, Cellular Immunology and Journal of Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.